Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Radioisotope and Patent Blue Dye in Sentinel Lymph Node Detection for Breast Cancer: a Randomized Controlled Trial

NCT05288686 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05288686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05288686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Radioisotope and Patent Blue Dye in Sentinel Lymph Node Detection for Breast Cancer: a Randomized Controlled Trial
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Unknown status
Start date
July 24, 2018
Completion date
June 30, 2024
Enrollment
282 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, sentinel lymph node